Nov. 13, 2024
DURHAM, NORTH CAROLINA – MED-EL Corporation announced that the U.S. Food and Drug Administration (FDA) has approved new indications for its cochlear implant system, including the first-ever approval related to hearing preservation outcomes. The updated indication in the United States now includes adults with bilateral moderate-to-profound sensorineural hearing loss and aided word recognition scores of 50% or less in the